The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: UK markets flat as Glaxo falls

Wed, 28th May 2014 08:37

- European stocks retreat from six-year highs- Economic data in focus- GSK to be investigated by UK fraud body- Weir drops pursuit of MetsotechMARK 2,784.94 -0.05%FTSE 100 6,838.75 -0.09%FTSE 250 15,885.65 +0.26%UK equities opened more or less flat on Wednesday as markets showed caution after stocks across Europe hit a six-year high the previous session.The FTSE 100 was trading 0.1% lower at 6,384 in early trading as investors awaited a wave of key economic data, including German unemployment, Eurozone consumer confidence and money supply figures.The Stoxx Europe 600 Index was trading 0.2% lower this morning after hitting 344.47 on Tuesday, its highest close since January 2008. Meanwhile, Germany's Dax index retreated after reaching a record high.Michael Hewson, Chief Market Analyst at CMC Markets UK, said that there is the prospect of further gains across Europe if today's economic data surprises to the upside, "as investors buy into a narrative of improving economic data and a backdrop of a further loosening of monetary policy from the European Central Bank at next week's rate meeting".GSK and Weir fall, RBS gainsThe Serious Fraud Office has opened a criminal investigation into the "commercial practices" of GlaxoSmithKline, causing shares in the pharmaceutical group to decline this morning. While details regarding this particular case are not yet known, the news will come as a further blow to shareholders after a wave of allegations against the company relating to international bribery.Engineering group Weir fell after dropping its pursuit to merge with Metso after continued rejections from the board of the Finnish rival. "Weir believes it made a compelling proposal but remains financially disciplined and therefore does not intend to pursue this opportunity further at this time," Weir said.Royal Bank of Scotland rose on reports that it is set to push through job cuts at its US mortgage business as the lender trims costs to avoid regulatory pressure from the Federal Reserve.Banknote printer De La Rue jumped after as reported a 43% surge in annual underlying operating profit and said it entered the new financial year with a good order book.Discretionary wealth manager Brewin Dolphin underwhelmed with a 25% increase in adjusted profits in the first half as the interim dividend came in slightly below forecasts.Serco gained after being selected to manage the new 15-year franchise for the Caledonian Sleeper service between London and several Scottish cities, taking over from current operator FirstGroup from April 2015.A host of stocks were automatically trading lower after going ex-dividend this morning, including heavyweights Marks & Spencer and Whitbread. Amec, Bellway, Britvic, Cable & Wireless Communications, Premier Farnell and Spectris also went ex-dividend today.FTSE 100 - RisersLondon Stock Exchange Group (LSE) 1,940.00p +1.78%Admiral Group (ADM) 1,413.00p +1.51%Rolls-Royce Holdings (RR.) 1,010.00p +1.20%Severn Trent (SVT) 1,919.00p +1.05%BT Group (BT.A) 396.00p +1.02%Experian (EXPN) 1,032.00p +0.88%Randgold Resources Ltd. (RRS) 4,464.00p +0.81%HSBC Holdings (HSBA) 626.00p +0.77%Sports Direct International (SPD) 796.00p +0.76%RSA Insurance Group (RSA) 479.40p +0.74%FTSE 100 - FallersMarks & Spencer Group (MKS) 444.20p -1.44%GlaxoSmithKline (GSK) 1,611.00p -1.44%Diageo (DGE) 1,879.00p -1.11%Morrison (Wm) Supermarkets (MRW) 197.80p -1.10%Johnson Matthey (JMAT) 3,307.00p -1.08%Coca-Cola HBC AG (CDI) (CCH) 1,359.00p -1.02%BHP Billiton (BLT) 1,928.00p -1.00%Tesco (TSCO) 299.80p -0.99%Burberry Group (BRBY) 1,514.00p -0.98%Barclays (BARC) 243.25p -0.92%FTSE 250 - RisersDe La Rue (DLAR) 847.50p +4.63%Betfair Group (BET) 1,019.00p +3.50%Lancashire Holdings Limited (LRE) 631.00p +2.44%Infinis Energy (INFI) 208.90p +2.40%Alent (ALNT) 319.10p +2.37%Ocado Group (OCDO) 352.50p +2.29%Halfords Group (HFD) 505.00p +2.23%Partnership Assurance Group (PA.) 127.60p +2.16%TalkTalk Telecom Group (TALK) 319.50p +2.08%Kazakhmys (KAZ) 270.30p +2.00%FTSE 250 - FallersAveva Group (AVV) 2,233.00p -4.98%Premier Farnell (PFL) 210.30p -2.68%Amec (AMEC) 1,174.00p -2.57%Cable & Wireless Communications (CWC) 54.45p -1.89%Brewin Dolphin Holdings (BRW) 298.40p -1.52%Rightmove (RMV) 2,305.00p -1.50%Barr (A.G.) (BAG) 629.50p -1.49%Bellway (BWY) 1,382.00p -1.36%Inchcape (INCH) 629.00p -1.33%Marston's (MARS) 152.50p -1.23%BC
More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.